Top news from MedWatch this week
Miss anything?
Monday
Lundbeck to prepare FDA filing based on promising Alzheimer’s data
ALK to start phase I trial of peanut allergy tablet vaccine
Tuesday
EMA awards priority status to Bavarian Nordic’s RSV vaccine for the over-60s
EMA starts assessment of Bavarian Nordic’s monkeypox vaccine
Wednesday
Stallergenes slapped with injunction
Fruergaard leveraging experience from Danish partnerships in key roles in Brussels
Thursday
Sanofi reduces US insulin prices for the uninsured
Life science firms are planning USD 6.3bn construction spree in Denmark
Friday
Genmab to submit cancer candidate epcoritamab to the FDA before year-end
Novo Nordisk denied general conditional reimbursement for Wegovy in Denmark – again
